TY - JOUR T1 - Is being able to walk to the letterbox life-changing? A qualitative assessment of measures of improvement in persistent breathlessness JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00530-2022 VL - 9 IS - 2 SP - 00530-2022 AU - Diana H. Ferreira AU - Magnus Ekström AU - Cornelia Verberkt AU - Daisy J.A. Janssen AU - David C. Currow Y1 - 2023/03/01 UR - http://openres.ersjournals.com/content/9/2/00530-2022.abstract N2 - Persistent breathlessness is a prevalent cause of disability in COPD [1]. Many people with COPD do not achieve acceptable symptom control despite optimisation of disease-specific and nonpharmacological treatments [2]. Regular, low-dose, sustained-release morphine may reduce persistent breathlessness in some people, noting wide interindividual variation in benefits and harms. Ideally, sustained-release morphine should only be prescribed to people who are likely to experience a net benefit. To date, the clinicodemographic characteristics of people most likely to benefit from sustained-release morphine for persistent breathlessness have not been defined. Benefits quantified need to reflect people's perceptions [3].Exploring clinically meaningful measures of improvement for people with persisting breathlessness https://bit.ly/3WaCzFh ER -